Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Its very close - are you ready ?????
Get ready for news release on Eye color. Get ready !!!
Funded Projects 2001
Grant Number: 001/2001
PI Name: Mirhashemi, Ramin and Arena, J. Fernando
Project Title: Pharmacogenomics Approach to Predict Chemotherapeutic Response to Ovarian Cancer Treatment.
Abstract: DESCRIPTION: (Adapted from investigator's abstract)
The goal of this project is to identify, qualify and quantify the genetic and environmental determinants of human variability in Ovarian Cancer chemotherapy response. To do this, we will explore the connection between human genetic variation (polymorphism), extrinsic factors (environment) and treatment response (phenotype) using state-of-the-art automated genomics equipment and genetic algorithms. Specifically, we will build a relational database containing patient genotype, phenotype and environmental data in order to "mine" statistically relevant associations and patterns using novel mathematical techniques. The specific drugs whose efficacy we will investigate are Adriamycin, Taxol, Topotecan and Thalidomide.
Of the many steps we will take in this project, the first is to identify novel SNP/Haplotypes for genes of suspected import to Ovarian Cancer chemotherapy. These genes include xenobiotic metabolism and basic cellular housekeeping genes such as tubulins and topoisomerases. For novel SNP/Haplotype discovery, we will use a relatively small (approx. 50) patient cohort. Entire regions of genes will be sequenced for these patients, and new SNPs discovered by comparing the sequences. New haplotypes for these SNPs and genes in the population will be documented. The genes that we will perform this for genes whose known functionality lend them as good candidates as modulators of chemotherapeutic drug efficacy. This particular phase of the study will address inadequacies with the current public human genome variation database (dbSNP). Since the public databaese relies on limited numbers of donors, who are generally healthy, it is necessarily biased against causative or etiologically relevant variants for most human afflictions. We will also mine the public human genome databases for known and undiscovered SNPs. All data mining for new SNPs will utilize a proprietary data mining software package developed at DNAprint genomics. The database of SNP locations and Haplotypes that results will contribute to a sort of "road map" which offers the opportunity to gain unique and valuable insight into Ovarian Cancer. This "road map" will serve as a guide by which the high-throughput experiments will be conducted.
The second step in our project will be to score these novel SNPs and Haplotypes in large patient cohorts. We will use the "road map" of SNP/HAP variability data with a larger study cohort (several hundreds of patients) to score genotypes in several hundred genes. SNPs and haplotypes will be scored using an automated genotyping platform and proprietary inferential informatics.
In addition to genotypes, matching biographical information such as drug dosage, response, environmental and other information will be collected and added to the relational database. This database will then be mined for associations using various mathematical techniques that consider sources of pattern on multiple levels of genetic complexity. Methodology types that will be used include geometric modeling, bayesian clustering, and artificial intelligence such as neural networks. Methodologies will incorporate various encoding schemes and genetic parameters, produced from the application of proprietary genetic algorithms and genetic grouping variables. Haplotype and sub-haplotype patterns will be investigated using pair-wise linkage disequilibria. New methods for improving the detection power for three-way and even four-way linkage disequilibria will be explored. Haplotypes will be inferred from genotype data. If successful, the project will culminate in the publication, patenting and commercialization of our results, which may eventually lead to a new diagnomics product that can be used with personal genetic information to guide patient chemotherapy treatment decisions.
Institution: UNIVERSITY OF MIAMI
1475 N. W. 12TH AVE.
MIAMI, FL 33136
Fiscal Year: 2001
Department: OB/GYN
Project Start: 01-January, 2001
Project End: 31-December, 2002
FUNDING AGENCY DNA PRINT GENOMICS
Address: DNAPrint genomics, Inc.900 Cocoanut Ave.Sarasota, FL 34236941-366-3400941-952-9770 fax
Grant Number: 002/2001
PI Name: Arena, J. Fernando
Project Title: Development of a BRCA1 and BRCA2 mutation screening assay for women of African descent.
Abstract: DESCRIPTION: (Adapted from investigator's abstract)
The long term objective of this application is to develop and to clinically validate a screening panel for specific BRCA1 and BRCA2 mutation/genetic variants in women of African descent with breast cancer. The development of such panel will allow its incorporation into clinical practice with clear improvement of genetic counseling for this minority population. African-American women under age 50 in the United States have the highest rate of new cases of breast cancer in the nation. In addition, African-American women of all ages have a larger percentage of poorly differentiated breast cancer, that is more likely to occur at an earlier age and to be estrogen and progesterone receptor negative - all factors associated with more aggressive tumorgenicity. Based on this preliminary data and a thorough review of all published English literature, we have identified thirteen mutations and thirteen unclassified variants in BRCA1 and six mutations and ten variants in BRCA2. A screening panel for such BRCA1 and BRCA2 mutations/variants will be designed to develop an efficient assay for eventual use in clinical practice. This assay is based on a combination of multiplex PCR and multiplex SSCP in order to provide a high throughput screening method for the above designated genetic alterations. SSCP variants will be further investigated by DNA sequencing to confirm the exact genetic change. The development of this screening panel will have an important impact on genetic counseling for women of African descent. It may also be helpful in anticipating the design of preventive strategies (mammography, chemoprevention, or prophylactic surgery) and in selecting appropriate therapeutic protocols for this underserved and under investigated patient population.
Institution: UNIVERSITY OF MIAMI
1475 N. W. 12TH AVE.
MIAMI, FL 33136
Fiscal Year: 2001
Department: OB/GYN
Project Start: 01-January, 2002
Project End: 31-December, 2003
FUNDING AGENCY Sylvester Comprehensive Cancer Center
Address: 1475 N.W. 12th Miami Fl, 33136
We have the POWER WE have the control We can make a difference.
Just type in "State police Lab. associations" in your search and your on your way.
What more do you want should i type it for you as well ? LOL come on ! Just do it.
Come on here's a another source to contact - http://www.neafs.org/officers.htm
Here's another site to help you make a list of contacts - http://www.neafs.org/labs.htm
Dont know where to look Try this - http://www.forensicpage.com/new07.htm
Look at all the E-Mails you can get from the Federal Gov. all the way down. Get people talking. Inform them bring them up to date.
Get up !! Get ready !! Make the List !! protect your interest !! Be involved !! Make a difference !! HELP OUT. What was said about the power of the pen ?
Dont Blow this off !!! It works !!! I've been there done it !! your selling a Dam good Comp. and product it sells it self. You only have to copy and paste, say very little in your own words just use the news release. Say something like Dear ***** This Comp. is helping to fight Crime in a Big Way >>>Then News release. Thats it !!! Not Hard !!! Do one a Day do 2 E-mails a day. Do something.
OK you dont want to do all that work. Then for God's sake do at least the town you live in.Its a seed you plant trust me it will grow. Hit the Mayor's office up as well he's the Boss to all Police Dept. It makes him look good when crime is solved in HIS TOWN.And if you have a Hard headed Chief of police the Mayor will over ride the chief, dont think he will not when the pressure is on.
IT would be a Great move by all here to get ready - I say to get ready for eye color to come out. How you say ? Make a File or note book on E-mail address to Police Dept. in every state in every city. Have at least 4 e-mails for each dept. starting from the Top down. MAKE the Dam List !!! when eye color comes out in the news Hit the list with copy and paste. I have already done it and it only took 8 to 9 weeks and i got a lot of good feed back.There's lots of work that can be done by us all here.There are many sources to tap into and get the word out.
It would be a GREAT MOVE by Dnap if they Merg with IQ Biometrix - http://www.policeone.com/police-technology/software/facial/press-releases/69840/ OR Smith & Wesson - http://swat.smithandwesson.com/jsp/Public/dsp_IdentiKit.jsp?Action=Info and offered a more complete package.
Another Comp. Marketing a Identy Kit. - -
http://swat.smithandwesson.com/jsp/Public/dsp_IdentiKit.jsp?Action=Info
IQ Biometrix Composite Software Helps Louisiana Police ID Suspect in Serial Killings
FREMONT, Calif. - announced today that the Sheriff's Office in St. Martin Parish, Louisiana confirmed that it used FACES composite software as one of several technologies to identify Derrick Todd Lee, recently arrested as the prime suspect in the killing of five women in south Louisiana.
Sheriff Mike Neustrom's office stated that, "The composite sketch developed with the FACES software was a significant aid in identifying the suspect in the killings of five women and rape of another. The composite created through witness interviews is a very close resemblance to the suspect."
About IQ Biometrix, Inc.
IQ Biometrix, Inc. (IQBM) provides law enforcement and security technology solutions for government and private industry. IQ Biometrix, an innovative California-based company is a leading provider of facial composite technology for law enforcement agencies in North America. FACES is currently used by thousands of policing agencies worldwide, including the Central Intelligence Agency and the Federal Bureau of Investigation. IQB is currently developing new applications based on this foundation technology tailored to meet the needs of national, business and personal security. Its solutions practice is focused on integrating IQB and partner technologies to provide customized responses to client needs. Further information about IQB can be found at .
More Valentine Traditions
The Language of Flowers
According to old traditions, sending different kinds of flowers sends a secret message to the one you love. Here are a few of these secret flower messages:
Red roses = I love you!
Yellow roses = I love you, but I don't know if you love me."
White roses = Our love is pure.
Four leaf clovers = a wish for good luck.
Orange blossoms = everlasting love.
Bleeding Heart = Hopeless, but not heartless.
Gardenia = I love you secretly.
Gladiolus = You pierce my heart.
Lily-of-the-Valley = Let us make up.
Rose - I love you passionately.
Sweet William = You are gallant, suave and perfect.
Violet = I return your love.
Green leaves represented hope in a love affair. (Often rumored to be the reason why British girls sprinkled bay leaves with rose water and put them on their pillows on Valentine's Day Eve. They wanted to see their loved one in their dreams.)
Fun Superstitions
On Valentine's Day, the first guy's name you read in the paper or hear on the TV or radio will be the name of the man you will marry.
If you see a squirrel on Valentine's Day, you will marry a cheapskate who will hoard all your money.
If you see a goldfinch on Valentine's Day, you will marry a millionaire.
If you see a flock of doves on Valentine's Day, you will have a happy, peaceful marriage.
If you find a glove on the road on Valentine's Day, your future beloved will have the other missing glove.
If you see a robin on Valentine's Day, you will marry a crime fighter
Valentine Traditions
Hundreds of years ago in England, many children dressed up as adults on Valentine's Day. They went singing from home to home. One verse they sang was:
Good morning to you, valentine;
Curl your locks as I do mine---
Two before and three behind.
Good morning to you, valentine.
In Wales wooden love spoons were carved and given as gifts on February 14th. Hearts, keys and keyholes were favorite decorations on the spoons. The decoration meant, "You unlock my heart!"
In the Middle Ages, young men and women drew names from a bowl to see who their valentines would be. They would wear these names on their sleeves for one week. To wear your heart on your sleeve now means that it is easy for other people to know how you are feeling.
In some countries, a young woman may receive a gift of clothing from a young man. If she keeps the gift, it means she will marry him.
Some people used to believe that if a woman saw a robin flying overhead on Valentine's Day, it meant she would marry a sailor. If she saw a sparrow, she would marry a poor man and be very happy. If she saw a goldfinch, she would marry a millionaire.
A love seat is a wide chair. It was first made to seat one woman and her wide dress. Later, the love seat or courting seat had two sections, often in an S-shape. In this way, a couple could sit together -- but not too closely!
Think of five or six names of boys or girls you might marry, As you twist the stem of an apple, recite the names until the stem comes off. You will marry the person whose name you were saying when the stem fell off.
Pick a dandelion that has gone to seed. Take a deep breath and blow the seeds into the wind. Count the seeds that remain on the stem. That is the number of children you will have.
If you cut an apple in half and count how many seeds are inside, you will also know how many children you will have.
St. valentine Day what is it ? well for your review -
Every February, across the country, candy, flowers, and gifts are exchanged between loved ones, all in the name of St. Valentine. But who is this mysterious saint and why do we celebrate this holiday?
The history of Valentine's Day -- and its patron saint -- is shrouded in mystery. But we do know that February has long been a month of romance. St. Valentine's Day, as we know it today, contains vestiges of both Christian and ancient Roman tradition.
So, who was Saint Valentine and how did he become associated with this ancient rite? Today, the Catholic Church recognizes at least three different saints named Valentine or Valentinus, all of whom were martyred. One legend contends that Valentine was a priest who served during the third century in Rome. When Emperor Claudius II decided that single men made better soldiers than those with wives and families, he outlawed marriage for young men -- his crop of potential soldiers. Valentine, realizing the injustice of the decree, defied Claudius and continued to perform marriages for young lovers in secret. When Valentine's actions were discovered, Claudius ordered that he be put to death. Other stories suggest that Valentine may have been killed for attempting to help Christians escape harsh Roman prisons where they were often beaten and tortured.
According to one legend, Valentine actually sent the first 'valentine' greeting himself. While in prison, it is believed that Valentine fell in love with a young girl -- who may have been his jailor's daughter -- who visited him during his confinement. Before his death, it is alleged that he wrote her a letter, which he signed 'From your Valentine,' an expression that is still in use today. Although the truth behind the Valentine legends is murky, the stories certainly emphasize his appeal as a sympathetic, heroic, and, most importantly, romantic figure. It's no surprise that by the Middle Ages, Valentine was one of the most popular saints in England and France.
While some believe that Valentine's Day is celebrated in the middle of February to commemorate the anniversary of Valentine's death or burial -- which probably occurred around 270 A.D -- others claim that the Christian church may have decided to celebrate Valentine's feast day in the middle of February in an effort to 'christianize' celebrations of the pagan Lupercalia festival. In ancient Rome, February was the official beginning of spring and was considered a time for purification. Houses were ritually cleansed by sweeping them out and then sprinkling salt and a type of wheat called spelt throughout their interiors. Lupercalia, which began at the ides of February, February 15, was a fertility festival dedicated to Faunus, the Roman god of agriculture, as well as to the Roman founders Romulus and Remus. To begin the festival, members of the Luperci, an order of Roman priests, would gather at the sacred cave where the infants Romulus and Remus, the founders of Rome, were believed to have been cared for by a she-wolf or lupa. The priests would then sacrifice a goat, for fertility, and a dog, for purification. The boys then sliced the goat's hide into strips, dipped them in the sacrificial blood and took to the streets, gently slapping both women and fields of crops with the goathide strips. Far from being fearful, Roman women welcomed being touched with the hides because it was believed the strips would make them more fertile in the coming year. Later in the day, according to legend, all the young women in the city would place their names in a big urn. The city's bachelors would then each choose a name out of the urn and become paired for the year with his chosen woman. These matches often ended in marriage.
Pope Gelasius declared February 14 St. Valentine's Day around 498 A.D. The Roman 'lottery' system for romantic pairing was deemed un-Christian and outlawed. Later, during the Middle Ages, it was commonly believed in France and England that February 14 was the beginning of birds' mating season, which added to the idea that the middle of February -- Valentine's Day -- should be a day for romance.
The oldest known valentine still in existence today was a poem written by Charles, Duke of Orleans to his wife while he was imprisoned in the Tower of London following his capture at the Battle of Agincourt. The greeting, which was written in 1415, is part of the manuscript collection of the British Library in London, England. Several years later, it is believed that King Henry V hired a writer named John Lydgate to compose a valentine note to Catherine of Valois.In Great Britain, Valentine's Day began to be popularly celebrated around the seventeenth century. By the middle of the eighteenth century, it was common for friends and lovers in all social classes to exchange small tokens of affection or handwritten notes. By the end of the century, printed cards began to replace written letters due to improvements in printing technology. Ready-made cards were an easy way for people to express their emotions in a time when direct expression of one's feelings was discouraged. Cheaper postage rates also contributed to an increase in the popularity of sending Valentine's Day greetings. Americans probably began exchanging hand-made valentines in the early 1700s. In the 1840s, Esther A. Howland began to sell the first mass-produced valentines in America.
According to the Greeting Card Association, an estimated one billion valentine cards are sent each year, making Valentine's Day the second largest card-sending holiday of the year. (An estimated 2.6 billion cards are sent for Christmas.) Approximately 85 percent of all valentines are purchased by women. In addition to the United States, Valentine's Day is celebrated in Canada, Mexico, the United Kingdom, France, and Australia.
2000 & 2001 & 2002 & 2003 & now 2004 Projects At University of Miami/Jackson Memorial Medical Center.This has got to be the last year.2005 for Ovarian Classifier to be submitted to the FDA then 2007 for approval.
12/15/00 - 12/15/02 DNA Print Genomics- Research Granst - P. I. Ramin Mirhashemi, M.D.. and J. Fernando Arena, M.D., Ph. D. - Pharmacogenomics Approach to the Treatment and Management of Ovarian Caner. At University of Miami/Jackson Memorial Medical Center.
Good night
OT- How about this one - Three Catholic women and a Jewish woman were discussing their families over coffee. The first Catholic woman tells her friends "My son is a priest. When he walks into a room, everyone calls him 'Father.'" The second woman chirps, "My son is a bishop. Whenever he walks into a room, people call him 'Your Grace.'" The third old woman says "My son is a cardinal. Whenever he walks into a room, he's called 'Your Eminence.'" As the little old Jewish lady sips her coffee in silence, the other three look at her and give her this subtle "Well...?" look, so she says: "My son is 6'4"; he has broad, square shoulders, lean hips and is very muscular; he's terribly handsome, has beautiful hair, dresses very well and always smells wonderful. Whenever he walks into a room, women say 'Oh, my God...'"
Ok one more - Adam was walking around the Garden of Eden feeling very lonely so God asked "Adam that is wrong with you?" Adam said he didn't have anyone to talk to. God said he was going to give him a companion and it would be a woman. He said this person will cook for you and wash your clothes, she will always agree with every decision you make. She will bear you children and never ask you to get up in the middle of the night to take care of them. She will not nag you, and will always be the first to admit she was wrong when you've had a disagreement. She will never have a headache, and will freely give you love and compassion whenever needed. Adam asked God what would a woman like this cost him?? God said "an arm and a leg". Adam foolishly asked "What can I get for just a rib?"
Ok I'll one Joke for you all and thats it. LOL - The Reverend Francis Norton woke up Sunday morning and realizing it was an exceptionally beautiful and sunny early spring day, decided he just had to play golf.
So... he told the Associate Pastor that he was feeling sick and convinced him to say Mass for him that day. As soon as the Associate Pastor left the room, Father Norton headed out of town to a golf course about forty miles away. This way he knew he wouldn`t accidentally meet anyone he knew from his parish.
Setting up on the first tee, he was alone. After all, it was Sunday morning and everyone else was in church!
At about this time, Saint Peter leaned over to the Lord while looking down from the heavens and exclaimed, "You`re not going to let him get away with this, are you?"
The Lord sighed, and said, "No, I guess not."
Just then Father Norton hit the ball and it shot straight towards the pin, dropping just short of it, rolled up and fell into the hole. It WAS A 420 YARD HOLE IN ONE! St. Peter was astonished.
He looked at the Lord and asked, "Why did you let him do that?"
The Lord smiled and replied, "Who`s he going to tell?"
A good source of what our Dnap is doing - http://rex.nci.nih.gov/behindthenews/ugt/ugtcontents.htm
To all for your review - http://www.ornl.gov/sci/techresources/Human_Genome/graphics/slides/images1.shtml
Tony ! Gmed is curing the kitchen sink for crying out loud give us something.
Tony ! For God's sake cut one for us will ya.
Tony where's da Beef !!!
Ming,yes I do know the relevance but i'm sorry to say I cant say much in this matter. Only what has been posted already.I cant even say why, but I can say it's a good source and a good lead.
Names to research on - Jose R. Fernandez {A Main Player};Mark T. Beasley; Roland L. Weinsier; Nashua Rafla Demetrious are all tied in to Mark Shriver and work at the University of Alabama at Birmingham.Heres info on Jose R. Fernandez - http://main.uab.edu/show.asp?durki=45336
I dont think Dr. M has anything active at the US Patent office.I'm glad i'm no longer in. Oh well God Bless him I wish him well.
OT this is all of them on Gmed and it dont look good. -
Nothing has been done since 08-08-2002-------
Search results for publication number:US 2003-0032598 A1
Application Number: 10/215,524 Customer Number: -
Filing or 371(c) Date: 08-08-2002
Status: Application Dispatched from Preexam, Not Yet Docketed
Application Type: Utility Status Date: 09-18-2002
Examiner Name: - Location: ELECTRONIC
Group Art Unit: 1614 Location Date: 12-01-2003
Confirmation Number: 8095 Earliest Publication No: US 2003-0032598 A1
Attorney Docket Number: GEN 103 Earliest Publication Date: 02-13-2003
Class/ Sub-Class: -/- Patent Number: -
First Named Inventor: David Moskowitz, St. Louis, MO (US) Issue Date of Patent: -
Title Of Invention: Method to treat pulmonary hypoplasia in the newborn
Select Search Option
Continuity Data Published Documents
File History
Number Date Contents Description
7 04-08-2003 Information Disclosure Statement (IDS) Filed
6 11-14-2002 Information Disclosure Statement (IDS) Filed
5 09-18-2002 Application Dispatched from OIPE
4 09-17-2002 Application Is Now Complete
2 08-21-2002 IFW Scan & PACR Auto Security Review
1 08-08-2002 Initial Exam Team nn
OT be careful on Gmed - here's another one !!!
Search results for publication number:US 2003-0032650 A1
Application Number: 10/215,962 Customer Number: -
Filing or 371(c) Date: 08-08-2002
Status: Non Final Action Mailed
Application Type: Utility
Status Date: 09-04-2003
Examiner Name: COOK, REBECCA Location: ELECTRONIC
Group Art Unit: 1614 Location Date: 02-07-2004
Confirmation Number: 8129 Earliest Publication No: US 2003-0032650 A1
Attorney Docket Number: GEN 101 Earliest Publication Date: 02-13-2003
Class/ Sub-Class: 514/263.35 Patent Number: -
First Named Inventor: David Moskowitz, St. Louis, MO (US) Issue Date of Patent: -
Title Of Invention: Treatment or prevention of acute renal failure
Select Search Option
Continuity Data Published Documents
File History
Number Date Contents Description
11 02-11-2004 Correspondence Address Change
10 09-04-2003 Mail Non-Final Rejection
9 09-03-2003 Non-Final Rejection
8 04-08-2003 Information Disclosure Statement (IDS) Filed
7 10-22-2002 Information Disclosure Statement (IDS) Filed
6 09-23-2002 Case Docketed to Examiner in GAU
5 09-16-2002 Application Dispatched from OIPE
4 09-13-2002 Application Is Now Complete
2 08-21-2002 IFW Scan & PACR Auto Security Review
1 08-08-2002 Initial Exam Team nn
OT Be Careful on Gmed - Another patent abandoned -
Search results for publication number:US 2002-0132234 A1
Application Number: 09/769,207 Customer Number: -
Filing or 371(c) Date: 01-24-2001 Status: Abandoned -- Failure to Respond to an Office Action
Application Type: Utility Status Date: 11-15-2002
Examiner Name: GOLDBERG, JEANINE ANNE Location: FILE REPOSITORY (FRANCONIA)
Group Art Unit: 1634 Location Date: 12-22-2003
Confirmation Number: 4868 Earliest Publication No: US 2002-0132234 A1
Attorney Docket Number: DZG 2165.1 Earliest Publication Date: 09-19-2002
Class/ Sub-Class: 514/100 Patent Number: -
First Named Inventor: David Moskowitz, St. Louis, MO Issue Date of Patent: -
Title Of Invention: Nitric oxide synthase gene diagnostic polymorphisms
OT on Gmed -
Total Assignments: 2
Patent #: NONE Issue Dt: Application #: 09769207 Filing Dt: 01/24/2001
Publication #: 20020132234 Pub Dt: 09/19/2002
Inventor: David W. Moskowitz
Title: Nitric oxide synthase gene diagnostic polymorphisms
Assignment: 1
Reel/Frame:
011487/0450 Recorded: 01/24/2001 Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
MOSKOWITZ, DAVID W.
Exec Dt: 01/23/2001
Assignee:
DZ GENES, L.L.C.
MOTHER CONCORDIA HALL, GROUND FLOOR
6420 CLAYTON ROAD
RICHMOND HEIGHTS, MISSOURI 63117
Correspondent:
SENNIGER, POWERS, LEAVITT & ROEDEL
JAMES E. BUTLER, PH.D.
ONE METROPOLITAN SQUARE, 16TH FLOOR
ST. LOUIS, MO 63102
Assignment: 2
Reel/Frame:
014172/0054 Recorded: 06/16/2003 Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
DZ GENES, LLC.
Exec Dt: 06/06/2003
Assignee:
VIRAL THERAPEUTICS, INC.
33 THORNWOOD DRIVE
SUITE 104
ITHACA, NEW YORK 14850
Correspondent:
SENNIGER, POWERS, LEAVITT ET AL.
EDWARD J. HEJLEK
ONE METROPOLITAN SQUARE
16TH FLOOR
ST. LOUIS, MO 63102
OT on Gmed - Be Careful - Patent rejection -
Search results for publication number:US 2002-0197632 A1
Application Number: 10/137,592 Customer Number: -
Filing or 371(c)
Date: 05-02-2002
Status: Non Final Action Mailed
Application Type: Utility Status Date: 12-18-2003
Examiner Name: SAKELARIS, SALLY A Location: ELECTRONIC
Group Art Unit: 1634 Location Date: 02-19-2003
Confirmation Number: 2611 Earliest Publication No: US 2002-0197632 A1
Attorney Docket Number: GEN 100 Earliest Publication Date: 12-26-2002
Class/ Sub-Class: 435/006 Patent Number: -
First Named Inventor: David Moskowitz, St. Louis, MO (US) Issue Date of Patent: -
Title Of Invention: Method to find disease-associated SNPs and genes
Select Search Option
Continuity Data Published Documents
File History
Number Date Contents Description
18 12-19-2003 Mail Non-Final Rejection
17 12-15-2003 Non-Final Rejection
16 10-06-2003 Date Forwarded to Examiner
15 10-02-2003 Response to Election / Restriction Filed
14 09-09-2003 Mail Restriction Requirement
13 09-08-2003 Requirement for Restriction / Election
12 07-31-2003 IFW TSS Processing by Tech Center Complete
11 08-13-2002 Information Disclosure Statement (IDS) Filed
10 09-23-2002 Case Docketed to Examiner in GAU
9 09-06-2002 Application Dispatched from OIPE
8 09-04-2002 Application Is Now Complete
7 08-05-2002 Additional Application Filing Fees
6 08-05-2002 A statement by one or more inventors satisfying the requirement under 35 USC 115, Oath of the Applic
5 07-15-2002 Notice Mailed--Application Incomplete--Filing Date Assigned
4 05-17-2002 IFW Scan & PACR Auto Security Review
3 05-15-2002 IFW Scan & PACR Auto Security Review
2 05-02-2002 Initial Exam Team nn
Chris, i have 600 shares